Enzyme-linked immunosorbent assays (ELISA) are the most common method for ligand binding assays, and are a core competency for the BioAgilytix team. We use ELISA in both its original and automation-powered forms as a fast, reliable, and cost-effective platform for analyte quantification of specific assays.
Learn More About the ELISA Method:
BioAgilytix’s experts are here to help. Let’s schedule a conversation to review your questions and requirements with one of our scientists.
The ELISA method is designed for detecting and quantifying substances such as peptides, proteins, antibodies and hormones, and is typically performed on a 96-well plate. Using ELISA, detection is completed by assessing the conjugated enzyme activity via incubation with a substrate to produce a measurable signal.
The binding and immobilization of reagents done through ELISA makes it easy to separate bound from non-bound material during the assay, and wash away non-specifically bound materials to measure specific analytes.
The ELISA technique was originally developed in the 1970s, when it was created as a replacement for traditional radioimmunoassay methods. More recently however, the ELISA method has been paired with laboratory automation techniques to dramatically improve throughput and sensitivity. Such advancements include automated plate washing and automated readouts.
The ELISA method is one of the most diverse available, with applications throughout health care and large molecule laboratory science. The platform comes in a variety of mechanisms, including direct, indirect, sandwich, competitive and ELISPOT, each with its own optimal applications.
As a bioanalytical laboratory that harnesses a variety of platforms, BioAgilytix most frequently leverages ELISA in our work with biomarkers, immunogenicity, pharmacokinetics (PK), and cell-based assays. ELISA can be leveraged in a multitude of research areas, including oncology, cardiovascular, neuroscience, and stem cell.
Platform In Action:
Learn how automation is helping analysts address growing pressures to increase efficiency and output with limited resources.
BioAgilytix offers ELISA services as a central competency, and has extensive experience developing and optimizing ELISA kits in conjunction with BioTek Synergy 2 plate reader instruments to increase reliability, sensitivity and specificity.
Our scientific team brings extensive, proven experience working with this popular platform to deliver high precision, high throughput assays, and most often leverage ELISA to meet our clients’ most demanding ligand-binding assay challenges.
Learn how we can support your unique assay requirements with the ELISA method today.